Literature DB >> 20512556

Immune infiltration in human cancer: prognostic significance and disease control.

Wolf H Fridman1, Jérome Galon, Marie-Caroline Dieu-Nosjean, Isabelle Cremer, Sylvain Fisson, Diane Damotte, Franck Pagès, Eric Tartour, Catherine Sautès-Fridman.   

Abstract

The interplay between tumors and their immunologic microenvironment is complex and difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. This chapter discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Thus, the fact that a strong infiltration of memory T cells with a Th1 and cytotoxic pattern is the strongest predictor for recurrence and metastasis is exemplified in colorectal cancer in which intratumoral chemokines shape an efficient immune reaction. Based on these data, we propose an immune score that predicts recurrence in early stage (UICC-TNM stage I-II) cancers. Studies on non-small lung cancers have confirmed findings of colorectal cancers and have addressed the question of the sites where antitumor immune reactions may take place. Tertiary lymphoid structures (TLS) adjacent to the tumor nest are sites of intense activity with mature dendritic cells in contact with T cells and germinal-like centers with proliferating B cells. The large number of these TLS being correlated with disease specific and overall survival tempts to postulate that they are privileged sites to mount an efficient antitumor reaction. Inflammation is a major component of human tumors and chronic inflammation is generally of bad prognosis. Head and neck cancers are highly inflammatory and two ways to modulate inflammation in these diseases are presented here: soluble IL-15 receptor α (IL-15 Rα) increases the pro-inflammatory effect of IL-15 and aggravates inflammation resulting in poor prognosis when found at high levels in the plasma of patients. By contrast, infiltration of regulatory T cells is paradoxically beneficial for local control of head and neck tumors, probably by "cooling down" the inflammatory process. The modulation of other aspects of innate immunity may also result in paradoxical effects such as the signaling through Toll like receptors 7 and 8 expressed on lung tumor cells which induce an aggressive tumoral phenotype. Finally, the analysis of primary intraocular lymphoma, which develops in the eye, exemplifies the induction of an antitumor immune reaction in an "immune sanctuary," presenting all the complexities of the tumor-immune interplay in "open" tissues such as the colon or the lung.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20512556     DOI: 10.1007/82_2010_46

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  94 in total

1.  Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Authors:  M Hardy-Werbin; O Arpí; A Taus; P Rocha; D Joseph-Pietras; L Nolan; S Danson; R Griffiths; M Lopez-Botet; A Rovira; J Albanell; C H Ottensmeier; E Arriola
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

Review 2.  Targeting angiogenesis in lung cancer - Pitfalls in drug development.

Authors:  Wolfgang Hilbe; Christian Manegold; Andreas Pircher
Journal:  Transl Lung Cancer Res       Date:  2012-06

3.  The density of macrophages in colorectal cancer is inversely correlated to TGF-β1 expression and patients' survival.

Authors:  Maya Gulubova; Julian Ananiev; Yovchev Yovchev; Aleksander Julianov; Anatoli Karashmalakov; Tatyana Vlaykova
Journal:  J Mol Histol       Date:  2013-06-26       Impact factor: 2.611

Review 4.  Cancer immunotherapy: Progress and challenges in the clinical setting.

Authors:  Hassane M Zarour; Soldano Ferrone
Journal:  Eur J Immunol       Date:  2011-06       Impact factor: 5.532

5.  Therapeutic vaccines for gastrointestinal cancers.

Authors:  Osama E Rahma; Samir N Khleif
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

6.  Claudin-low bladder tumors are immune infiltrated and actively immune suppressed.

Authors:  Jordan Kardos; Shengjie Chai; Lisle E Mose; Sara R Selitsky; Bhavani Krishnan; Ryoichi Saito; Michael D Iglesia; Matthew I Milowsky; Joel S Parker; William Y Kim; Benjamin G Vincent
Journal:  JCI Insight       Date:  2016-03-17

7.  Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.

Authors:  Ileana S Mauldin; Nolan A Wages; Anne M Stowman; Ena Wang; Mark E Smolkin; Walter C Olson; Donna H Deacon; Kelly T Smith; Nadedja V Galeassi; Kimberly A Chianese-Bullock; Lynn T Dengel; Francesco M Marincola; Gina R Petroni; David W Mullins; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2016-08-13       Impact factor: 6.968

8.  Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy.

Authors:  Joshua P Landreneau; Michael R Shurin; Marianna V Agassandian; Anton A Keskinov; Yang Ma; Galina V Shurin
Journal:  Cancer Microenviron       Date:  2013-11-29

Review 9.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

Review 10.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.